Winters IP - Search Results

1

Tumor Suppressor Activity of Selenbp1, a Direct Nkx2-1 Target, in Lung Adenocarcinoma.

Caswell DR, Chuang CH, Ma RK, Winters IP, Snyder EL, Winslow MM. Caswell DR, et al. Among authors: winters ip. Mol Cancer Res. 2018 Nov;16(11):1737-1749. doi: 10.1158/1541-7786.MCR-18-0392. Epub 2018 Jul 12. Mol Cancer Res. 2018. PMID: 30002193 Free PMC article.

2

Pancreatic cancer modeling using retrograde viral vector delivery and in vivo CRISPR/Cas9-mediated somatic genome editing.

Chiou SH, Winters IP, Wang J, Naranjo S, Dudgeon C, Tamburini FB, Brady JJ, Yang D, Grüner BM, Chuang CH, Caswell DR, Zeng H, Chu P, Kim GE, Carpizo DR, Kim SK, Winslow MM. Chiou SH, et al. Among authors: winters ip. Genes Dev. 2015 Jul 15;29(14):1576-85. doi: 10.1101/gad.264861.115. Epub 2015 Jul 15. Genes Dev. 2015. PMID: 26178787 Free PMC article.

3

A quantitative and multiplexed approach to uncover the fitness landscape of tumor suppression in vivo.

Rogers ZN, McFarland CD, Winters IP, Naranjo S, Chuang CH, Petrov D, Winslow MM. Rogers ZN, et al. Among authors: winters ip. Nat Methods. 2017 Jul;14(7):737-742. doi: 10.1038/nmeth.4297. Epub 2017 May 22. Nat Methods. 2017. PMID: 28530655 Free PMC article.

4

Multiplexed in vivo homology-directed repair and tumor barcoding enables parallel quantification of Kras variant oncogenicity.

Winters IP, Chiou SH, Paulk NK, McFarland CD, Lalgudi PV, Ma RK, Lisowski L, Connolly AJ, Petrov DA, Kay MA, Winslow MM. Winters IP, et al. Nat Commun. 2017 Dec 12;8(1):2053. doi: 10.1038/s41467-017-01519-y. Nat Commun. 2017. PMID: 29233960 Free PMC article.

5

Mapping the in vivo fitness landscape of lung adenocarcinoma tumor suppression in mice.

Rogers ZN, McFarland CD, Winters IP, Seoane JA, Brady JJ, Yoon S, Curtis C, Petrov DA, Winslow MM. Rogers ZN, et al. Among authors: winters ip. Nat Genet. 2018 Apr;50(4):483-486. doi: 10.1038/s41588-018-0083-2. Epub 2018 Apr 2. Nat Genet. 2018. PMID: 29610476 Free PMC article.

6

Towards quantitative and multiplexed in vivo functional cancer genomics.

Winters IP, Murray CW, Winslow MM. Winters IP, et al. Nat Rev Genet. 2018 Dec;19(12):741-755. doi: 10.1038/s41576-018-0053-7. Nat Rev Genet. 2018. PMID: 30267031 Review.

7

Publisher Correction: Towards quantitative and multiplexed in vivo functional cancer genomics.

Winters IP, Murray CW, Winslow MM. Winters IP, et al. Nat Rev Genet. 2018 Dec;19(12):801. doi: 10.1038/s41576-018-0062-6. Nat Rev Genet. 2018. PMID: 30327497

8

An LKB1-SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation.

Murray CW, Brady JJ, Tsai MK, Li C, Winters IP, Tang R, Andrejka L, Ma RK, Kunder CA, Chu P, Winslow MM. Murray CW, et al. Among authors: winters ip. Cancer Discov. 2019 Nov;9(11):1590-1605. doi: 10.1158/2159-8290.CD-18-1237. Epub 2019 Jul 26. Cancer Discov. 2019. PMID: 31350327 Free PMC article.

9

Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.

Bieging-Rolett KT, Kaiser AM, Morgens DW, Boutelle AM, Seoane JA, Van Nostrand EL, Zhu C, Houlihan SL, Mello SS, Yee BA, McClendon J, Pierce SE, Winters IP, Wang M, Connolly AJ, Lowe SW, Curtis C, Yeo GW, Winslow MM, Bassik MC, Attardi LD. Bieging-Rolett KT, et al. Among authors: winters ip. Mol Cell. 2020 Nov 5;80(3):452-469.e9. doi: 10.1016/j.molcel.2020.10.022. Mol Cell. 2020. PMID: 33157015 Free PMC article.

10

Quantitative In Vivo Analyses Reveal a Complex Pharmacogenomic Landscape in Lung Adenocarcinoma.

Li C, Lin WY, Rizvi H, Cai H, McFarland CD, Rogers ZN, Yousefi M, Winters IP, Rudin CM, Petrov DA, Winslow MM. Li C, et al. Among authors: winters ip. Cancer Res. 2021 Sep 1;81(17):4570-4580. doi: 10.1158/0008-5472.CAN-21-0716. Epub 2021 Jul 2. Cancer Res. 2021. PMID: 34215621 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page